The Promise and Perils of Biotech in Personalised Healthcare. Can New Regulatory Pathways Protect the Vulnerable?

Risk and Regulation Magazine 32 (Winter 2018):20-23 (2018)
  Copy   BIBTEX


The paper discusses some of the implications of regulatory innovation in the area of advanced biological therapies and personalised medicine. Benefits, risks and trade-offs are highlighted.

Author's Profile

Giovanni De Grandis
Norwegian University of Science and Technology


Added to PP

73 (#61,771)

6 months
12 (#59,803)

Historical graph of downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.
How can I increase my downloads?